Halma (LSE: HLMA) has long been viewed as one of the FTSE 100’s highest-quality compounders, with steady growth and consistent execution. That’s why the recent sharp share price fall after FY26 results has caught many investors off guard.
At first glance, nothing obvious appears broken in the underlying business. The question is whether the sell-off has created an attractive entry point for long-term investors — or whether the market’s reacting to something more subtle.
The compounding model behind the consistency
The key insight from the results is not the headline numbers, but the structure that produces them. This is a decentralised group built around specialist businesses operating in niche, high-growth markets. Each unit runs its own strategy, but all are linked by a central discipline: strong cash generation is continuously recycled into reinvestment.
That reinvestment loop’s the real engine. High margins and cash conversion fund both organic R&D and acquisitions, which in turn expand the future earnings base. Importantly, this isn’t a recent shift — it’s a model that has delivered consistent double-digit revenue and profit growth over two decades.
What stands out is how self-reinforcing the system has become. Strong performance doesn’t lead to payout pressure or conservatism. It leads to further investment, which supports the next phase of growth.
That’s the foundation the market has historically paid up for.
Where recent growth’s distorting the picture
What’s becoming more interesting is how a small number of unusually strong growth drivers are shaping that model.
The photonics business has clearly acted as a meaningful tailwind, and management acknowledges that its contribution has been unusually strong in both scale and timing. This has helped lift overall group performance, but it can also make the underlying run-rate harder for investors to interpret in the short term.
At the same time, the group’s reinvesting at record levels, with more than £600m allocated to R&D and acquisitions. This is important because it reinforces the compounding model, rather than relying on short-term cash generation or higher payouts.
Put together, this means headline growth may not fully reflect how evenly the business generates performance across its different parts. Some segments are contributing more than others at this point in the cycle.
The key question for investors is whether the market’s interpreting recent results as a new sustainable growth rate — or simply a period where a few unusually strong drivers are temporarily amplifying the underlying trend.
What could go wrong
The main risk isn’t that the model stops working, but that expectations move ahead of what can be delivered in any single year. When a business compounds steadily over long periods, even small changes in mix or timing can drive sharp sentiment shifts.
There’s execution risk around the scale of ongoing reinvestment, particularly given how central acquisitions and R&D remain to future growth.
That said, this remains one of the more consistent long-term compounders in the FTSE 100, supported by a model that has delivered through multiple cycles.
For long-term investors, recent share price weakness may have created an attractive entry point. That’s why I think this is one to consider.
Should you invest £5,000 in Halma Plc right now?
When investing expert Mark Rogers and his team have a stock tip, it can pay to listen. After all, the flagship Twelfth Magpie Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.
And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Halma Plc made the list?
Andrew Mackie does not hold any positions in the companies mentioned.
